Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vistagen Therapeutics, Inc. - Common Stock
(NQ:
VTGN
)
0.6452
-0.0186 (-2.80%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vistagen Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
These stocks have an unusual volume in today's session
↗
December 22, 2025
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
↗
December 19, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look.
↗
December 18, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via
Chartmill
Why Did Vistagen Stock Tank 82% Today?
↗
December 17, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 17, 2025
Via
Benzinga
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Insights into VistaGen Therapeutics's Upcoming Earnings
↗
June 16, 2025
Via
Benzinga
Vistagen (VTGN) Q2 2026 Earnings Call Transcript
↗
November 14, 2025
Vistagen (VTGN) Q2 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Examining the Future: VistaGen Therapeutics's Earnings Outlook
↗
November 12, 2025
Via
Benzinga
Vistagen (VTGN) Q1 R&D Expense Jumps 54%
↗
August 07, 2025
Via
The Motley Fool
Insights Ahead: VistaGen Therapeutics's Quarterly Earnings
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For June 17, 2025
↗
June 17, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
↗
February 13, 2025
Via
Benzinga
Recap: Vistagen Therapeutics Q3 Earnings
↗
February 13, 2024
Via
Benzinga
VistaGen Therapeutics's Earnings: A Preview
↗
February 12, 2024
Via
Benzinga
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025
↗
August 13, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
Via
InvestorPlace
3 Stocks Under $15 That Could Make You a Millionaire
↗
July 26, 2024
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying.
Via
InvestorPlace
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
↗
June 12, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via
InvestorPlace
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio
↗
May 14, 2024
Though volatility remains high, these penny stocks promise significant returns, especially in this high-interest rate economic climate.
Via
InvestorPlace
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence
↗
May 13, 2024
The internet and forums such as Reddit, are rife with misinformation about stock prospects. However, these three might have potential.
Via
InvestorPlace
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
↗
April 19, 2024
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.
Via
InvestorPlace
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
↗
April 09, 2024
Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology.
Via
InvestorPlace
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027
↗
March 31, 2024
Learn the potency of lesser-known stocks and explore their fundamental edge in technology distribution, food retail, and biotechnology.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
February 19, 2024
Via
Benzinga
3 Revolutionary Biotech Stocks Poised for 10X Surge
↗
February 19, 2024
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.
Via
InvestorPlace
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
↗
February 14, 2024
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.
Via
InvestorPlace
Earnings Scheduled For February 13, 2024
↗
February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via
Benzinga
3 Penny Stocks to Buy for the Next Bull Run: February 2024
↗
February 07, 2024
As the market pivots in 2024, dive into the dynamic world of penny stocks, revealing the top choices for February's exhilarating bull run.
Via
InvestorPlace
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
↗
January 26, 2024
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.
Via
InvestorPlace
Topics
Economy
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
